echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The Le Yingying Research Group of the Institute of Nutrition and Health reveals the mechanism of vitamin D deficiency in obesity and related metabolic diseases

    The Le Yingying Research Group of the Institute of Nutrition and Health reveals the mechanism of vitamin D deficiency in obesity and related metabolic diseases

    • Last Update: 2021-09-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 27, 2021, the Le Yingying Research Group of the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences published an online publication entitled "High Fat Diet and High Cholesterol Diet Reduce Hepatic Vitamin D-25-Hydroxylase" in the international academic journal Molecular Nutrition & Food Research .


    Vitamin D is an essential vitamin for the human body.


    Epidemiological studies have shown that people with obesity and related metabolic diseases (hyperlipidemia, insulin resistance, type 2 diabetes) have insufficient vitamin D (blood 25(OH)D 21-30 ng/ml) or lack of vitamin D (blood 25( OH)D <20 ng/ml), and vitamin D supplementation cannot effectively increase blood 25(OH)D levels


    In this study, the researchers first used high-fat, high-cholesterol diet-induced obesity and glucose and lipid metabolism mouse models combined with in vitro experiments to explore the causes and mechanisms of vitamin D deficiency


    The researchers further used high-fat diet-induced obesity and metabolic disorder model mice to observe whether reducing body weight and improving glucose and lipid metabolism disorders by restricting diet can improve vitamin D metabolism


    In summary, the study used diet-induced obesity and glucose and lipid metabolism animal models, combined with in vitro experiments and diet restriction experiments, and found that blood cholesterol, blood sugar, and insulin increased by inhibiting liver Cyp2r1 expression led to a decrease in blood circulation 25(OH)D ; It is suggested to avoid high-fat, high-cholesterol diet, and treat obesity and glucose and lipid metabolism disorders not only to improve vitamin D metabolism and vitamin D deficiency, but also to enhance the efficacy of vitamin D supplementation by increasing liver Cyp2r1 levels


    Zhu Tengfei, a doctoral student at the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, is the first author of the paper, and researcher Le Yingying is the corresponding author



    Article link: https://onlinelibrary.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.